HI SB332 | 2019 | Regular Session

Note: Carry Foward to future SB332

Status

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 18 2019 - 25% progression, died in committee
Action: 2019-01-22 - Referred to CPH, WAM.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Exempts the sales of mobility enhancing equipment sold by prescription, prosthetic devices, prescription drugs sold pursuant to a prescription, diabetic supplies, medical oxygen, and human blood and its derivatives from the general excise tax for taxable years beginning after December 31, 2018. Amends the definitions of "prosthetic device" and "prescription drugs".

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To The General Excise Tax.

Sponsors


History

DateChamberAction
2019-01-22SenateReferred to CPH, WAM.
2019-01-22SenatePassed First Reading.
2019-01-18SenateIntroduced.

Same As/Similar To

SB332 (Carry Over) 2019-01-22 - Referred to CPH, WAM.
HB632 (Same As) 2019-03-05 - Referred to CPH, WAM.

Subjects


Hawaii State Sources


Bill Comments

feedback